| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/29/2008 | US7365153 Biologically active peptide and agent containing the same |
| 04/29/2008 | US7365083 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 04/29/2008 | US7365079 2-(2-naphthyl)-4'-[3-oxospiro[6-azaisobenzofuran-1(3H),1-cyclohexan]-4'-yl]-1H-imidazole; metabolic, genitalor reproductive, gastro-intestinal, respiratory system disorders, antiinflammatory agent or glaucoma; cyclization |
| 04/29/2008 | US7365077 Obesity, type 2 diabetes, sleep disorders, ischaemic or haemorrhagic strokes, antiemetic; toxicity; side effect reduction; 2-((benzofuran-4-yl)carbonylaminomethyl)-1-((4-(5-(4-fluorophenyl)-2-methyl)thiazolyl)carbonyl)-4-methylpiperazine |
| 04/29/2008 | US7365067 Neurokinin receptors antagonists; asthma, bronchitis and chronic obstructive lung disease; allergic diseases such as rhinitis, urinary incontinence; 1-(2-{(2R)-2-(3,4dichlorophenyl)-4-[3,5-bis(trifluoromethyl)benzoyl]morpholin-2-yl}ethyl)spiro((2S)-2-{[(morpholin-1-yl)acetyl]oxy})indane-1,4'-piperidine |
| 04/29/2008 | US7365064 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them |
| 04/29/2008 | US7365062 4-(2-fluorophenylbenzoyl-4-aminobenzoyl)-3'-(2-(N,N-dimethylaminoethylaminocarbonyl))-4-aza-[6,4]-spiro-[5,6]-benzoundec-2'-ene; hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure, cerebral edema or ischemia |
| 04/29/2008 | US7365052 Tendon-inducing methods |
| 04/29/2008 | US7365049 Afamin-containing compositions and methods of use |
| 04/29/2008 | US7364867 Nucleotide sequences which code a membrane protein for use in flavor intensification of in food, beverages or pharmaceuticals |
| 04/29/2008 | US7364847 nucleic acid that binds to high mobility group protein-I (HMG-I), and causes presenilin-2 gene exon 5-lacked type aberrant splicing by the association with the HMG-I protein; an inhibitor for inhibiting a binding between protein-nucleic acid caused by aberrant splicing; drug screening; antisense agents |
| 04/29/2008 | US7364845 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, psoriasis and nervous system disorders |
| 04/29/2008 | US7364751 By adding an antioxidant and/or a chelating agent in the same aqueous solution; reduced coenzyme Q10, vitamin C and ethylenediaminetetracetic acid for example |
| 04/29/2008 | US7364735 Method for diagnosis and treatment of haemophilia A patients with an inhibitor |
| 04/29/2008 | US7364730 Human K+ channel and prognosing applications thereof |
| 04/29/2008 | US7364722 Pharmaceutical and cosmetic compositions comprising plgf-1 |
| 04/29/2008 | CA2336474C C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 04/29/2008 | CA2321188C Derivatives of azetidine and pyrrolidine |
| 04/29/2008 | CA2315329C Improved hmg coa reductase inhibitor extended release formulation |
| 04/29/2008 | CA2304712C Endothelin antagonist and a renin-angiotensin system inhibitor as a combined preparation |
| 04/29/2008 | CA2283572C Bifurcated method to process aloe whole leaf |
| 04/29/2008 | CA2272711C Method for treating renal failure |
| 04/29/2008 | CA2254833C Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 04/29/2008 | CA2250485C Diagnostic agent for diabetes |
| 04/29/2008 | CA2245484C Novel urea derivatives |
| 04/29/2008 | CA2218887C Piperazino derivatives as neurokinin antagonists |
| 04/29/2008 | CA2120353C Cell cycle controlling compositions and methods of using same |
| 04/24/2008 | WO2008049121A2 Hydroxycitric acid compositions, methods of making, and therapeutic uses of same |
| 04/24/2008 | WO2008048074A1 Use of core-shell gold nanoparticle which contains magnetic nanoparticles for mri t2 contrast agent, cancer diagnostic and therapy |
| 04/24/2008 | WO2008047839A1 5-ht1a receptor agonist |
| 04/24/2008 | WO2008047831A1 Jak inhibitor |
| 04/24/2008 | WO2008047821A1 Fused heterocyclic compound |
| 04/24/2008 | WO2008047758A1 Antiinflammatory agent comprising 2-aminophenol or derivative thereof as active ingredient |
| 04/24/2008 | WO2008047723A1 Diagnosis and treatment of cancer using anti-ereg antibody |
| 04/24/2008 | WO2008047709A1 Nk1 receptor antagonist composition |
| 04/24/2008 | WO2008047681A1 Benzimidazole compound having gastric acid secretion inhibitory activity |
| 04/24/2008 | WO2008047663A1 Activity enhancer for detoxifying enzyme |
| 04/24/2008 | WO2008047633A1 Aliphatic compound-containing skin whitening agent |
| 04/24/2008 | WO2008047544A1 Diaryl ketimine derivative |
| 04/24/2008 | WO2008009638A3 New indications for direct thrombin inhibitors in the cardiovascular field |
| 04/24/2008 | US20080097385 Therapeutic Adjuncts to Enhance the Organ Protective Effects of Postconditioning |
| 04/24/2008 | US20080097219 Clostridial toxin by injection; qualitative, quantitative assessment of physiological activity of a target site under resting and non-resting conditions; muscle surface, skin surface, organ surface, gland surface; medicine, veterinary medicine, pharmacy, dentistry |
| 04/24/2008 | US20080097102 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
| 04/24/2008 | US20080096969 L-N alpha -(menthanecarboxyl)glycine-N-isobutylamide; mixture additionally cause a flavor-modulating effect and/or a trigeminal and/or a salivatory stimulus; on the skin and/or mucous membranes; for nutrition, pleasure, oral hygiene, a pharmaceutical, or a cosmetic; nonhydrolyzing |
| 04/24/2008 | US20080096957 Albumin-Binding Conjugates Comprising a Fatty Acid and Peg |
| 04/24/2008 | US20080096952 Methods for the treatment of atherosclerosis, using substituted phenethylsulfones |
| 04/24/2008 | US20080096950 Compounds Useful In Therapy |
| 04/24/2008 | US20080096949 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 04/24/2008 | US20080096942 Beta-secretase inhibitors; use in treating Alzheimer's disease; for example, N-{(1S,2R)-1-[3-(cyclohexylmethyl)benzyl]-2-hydroxy-3-[(3-methoxybenzyl)amino]propyl}acetamide hydrochloride |
| 04/24/2008 | US20080096936 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/24/2008 | US20080096925 Analgesics for neuropathy, surgery, nervous system disorders, headaches, arthritis, psoriasis, respiratory system disorders, and gastrointestinal disorders; ethyl 4-phenyl-4-[1-(phenylmethyl)-1H-imidazol-2-yl]-1-piperidinecarboxylate; |
| 04/24/2008 | US20080096922 N-{[cis-1-(3-methoxyphenyl)-4-(piperidin-4-ylamino)-cyclohexyl]methyl}sulfamide diHCL; tert-butyl [({[cis-4-[(biphenyl-4-ylmethyl)amino]-1-(3-methoxyphenyl)cyclohexyl]methyl}amino)sulfonyl]carbamate; for potentiating expression of low density lipoprotein recepotr; arteriosclerosis; hyperlipidemia |
| 04/24/2008 | US20080096909 Alzheimer's disease; alkoxy-, hydroxy-, alkylthio-, or mercapto-substituted naphtho[ab,ij]isoquinolinium compounds, as well as oxidation or autooxidation products; side effect reduction |
| 04/24/2008 | US20080096890 Highly Selective Norepinephrine Reuptake Inhibitors and Methods of Using the Same |
| 04/24/2008 | US20080096883 Trifluoromethyl substituted benzamides as kinase inhibitors |
| 04/24/2008 | US20080096880 Use of imidazo[1,2,4]triazinones which are inhibitors of cGMP-metabolizing phosphodiesterases (PDE I, II and V) to treat cardiovascular disorders, urogenital disorders, prostate hyperplasia, ocular disorders such as glaucoma, optic neuropathy, diabetic gastroparesis, dementia |
| 04/24/2008 | US20080096865 Improved photodynamic treatment against subfoveal choroidal neovascularization; administering midostaurin, vatalanib dihydrochloride or octreotide with a photosensitive porphyrin or purpurin; angiogenesis inhibition |
| 04/24/2008 | US20080096856 Antibiotic Compound |
| 04/24/2008 | US20080096840 Gene expression inhibition by contacting cells which express kinase suppressor of Ras (KSR) with a nucleic acid which is complementary to a portion of the mRNA encoding KSR; antitumor, anticarcinogenic, antimetastasis and antiproliferative agents |
| 04/24/2008 | US20080096838 Guanosine rich oligonucleotides and methods of inducing apoptosis in tumor cells |
| 04/24/2008 | US20080096837 Defective sindbis viral vectors |
| 04/24/2008 | US20080096836 Contacting sample of heterogenous protein from blood, lymph or cerebrospinal fluid or protein expression library such as a wound site-, a lambda wound site expression-, or a phage display library with compound from saliva or salivary glands of a blood-feeding parasite; isolating ligand or receptor |
| 04/24/2008 | US20080096821 Cytostatin II |
| 04/24/2008 | US20080096819 Amino acid substituted molecules |
| 04/24/2008 | US20080096809 Diastereomeric Peptides Useful as Inhibitors of Membrane Protein Assembly |
| 04/24/2008 | US20080096808 co-administering the protein replacement therapy with rapamycin, to inhibiting the immune response of a host to protein replacement therapy; immunology modulators |
| 04/24/2008 | US20080096802 administering peroxisome proliferator-activated receptor agonists (PPAR) and sodium glucose co-transporters (SGLTs) inhibitors for the treatment of diabetes and Syndrome X |
| 04/24/2008 | US20080096798 administering a first peptide comprising 10 to 50 amino acid residues and a second protein selected from bone morphogenic proteins, transforming growth, epidermal growth, epithelial cell growth, fibroblast growth, platelet derived growth or insulin-like growth factors, to enhance regeneration of bones |
| 04/24/2008 | US20080096796 Peptides That Stimulate Cell Survival and Axon Regeneration |
| 04/24/2008 | US20080096795 Novel Antiangiogenic Peptide Agents and Their Therapeutic and Diagnostic Use |
| 04/24/2008 | US20080096794 proteins used for the prevention and/or treatment of tumors, development disorders, autoimmune diseases,allergies and inflammations; foods or nutraceuticals |
| 04/24/2008 | US20080096250 Expression vector comprising nucleotide sequences coding inflammatory response polypeptide for use in treatment and prevention of inflammation |
| 04/24/2008 | US20080095872 using modified Clostridial toxin having an orphanin targeting moiety, a domain for translocating a light chain across an endosome membrane; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction |
| 04/24/2008 | US20080095867 extracting and reacting the hydroxycitric acid with IA and IIA group metals of periodic table, isolating the metal salt and drying and optionally mixing anthocyanins to obtain the synergistic compositions; beverages and powdered beverage premixes |
| 04/24/2008 | US20080095859 Formulations and Treatments for Well-Being |
| 04/24/2008 | US20080095858 Detecting restriction fragment length polymorphisms associated with liver disorders; multidrug resistance gene (MDR) |
| 04/24/2008 | US20080095855 Taste Masking Granules |
| 04/24/2008 | US20080095854 Ballast administering to mammals skins; high density core overcoated with amorphous reservoir containing dna; drug delivery; containing free radical scavenger |
| 04/24/2008 | US20080095842 Rapidly Disintegrating Taste Masked Compositions and a Process for Its Preparations |
| 04/24/2008 | US20080095837 Human growth hormone formulations |
| 04/24/2008 | US20080095834 Mitochondriotropic Phospholipid Vesicles |
| 04/24/2008 | US20080095827 Nutritional weight loss agent and method |
| 04/24/2008 | US20080095819 Antiproliferative agents; connexins; reducing density of astrocytes; increasing density of neurons; hair growth; cosmetic surgery |
| 04/24/2008 | US20080095811 Methods of bleaching teeth using adhesive dental bleaching compositions containing polyvinylpyrrolidone |
| 04/24/2008 | US20080095804 Two-step immunization procedure against chlamydia infection |
| 04/24/2008 | US20080095803 Protein matrix vaccines and methods of making and administering such vaccines |
| 04/24/2008 | US20080095797 Marek's disease virus having a mutation in one or both Meq genes thereof such that the virus is non-pathogenic; vaccines; for prevention or treatment of Marek's disease in poultry |
| 04/24/2008 | US20080095794 Recombinant bcg strains with enhanced ability to escape the endosome |
| 04/24/2008 | US20080095793 Expression vector comprising nucleotide sequences coding protein fusion for use in treatment and prevention of microorganismal infection |
| 04/24/2008 | US20080095792 Polypeptides For Inducing A Protective Immune Response Against Staphylococcus Aureus |
| 04/24/2008 | US20080095788 Vaccines |
| 04/24/2008 | US20080095783 Monoclonal antibody specific to Lewis Y antigen for enhancing antibody dependent cell-mediated cytotoxicity and treatment of cell proliferative disorders; immunotherapy; tissue targeted therapy |
| 04/24/2008 | US20080095776 Erythropoietin receptor binding antibodies |
| 04/24/2008 | US20080095775 Immunoglobulin for use in prevention and treatment of diabetes, arthritis, autoimmune, skin, respiratory and inflammatory disorders; immunotherapy |
| 04/24/2008 | US20080095772 Antibodies against human parathyroid hormone related protein |
| 04/24/2008 | US20080095768 Use of allogeneic effector cells and anti-cs1 antibodies for selective killing of multiple myeloma cells |
| 04/24/2008 | US20080095764 Use of genetically-and epigenetically-altered protocadherins in methods of diagnosing, prognosing, and treating cancer |
| 04/24/2008 | US20080095763 Using cyclin dependent kinase -9 (CDK9) as diagnostic tool in identifying modulators of insulin like growth factor function; antitumor agents; antihypoxic agents |
| 04/24/2008 | US20080095762 Glycoprotein compositions |
| 04/24/2008 | US20080095758 Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |